what to know when starting glp 1 GLP-1s: Users Wish They Knew, and How Feel More Confident From Day One Starting a GLP-1 medication? Knowing

Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines' expression in adipocytes and cancer cells

10.36721/pjps.2023.36.4.Reg.1217-1225.1 28 FattahN.DarwishY

We are entering an era where treatments are not only managing conditions but actively improving overall metabolic health and long-term outcomes

furthermore, weight loss of 5% to 19% of body weight, depending on the agent, has been documented

& Laragh, J

Dose-response improvements in glycaemic control and body weight reduction with HM11260C, a once weekly GLP-1 receptor agonist with liraglutide as reference, in type 2 diabetes.[abstract]